Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small-Cell Carcinoma of the Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07596654
What this trial is testing

The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer

Who this might be right for
Esophageal CarcinomaLimited-Stage Small Cell Esophageal Carcinoma
yi shen 4
Testing effectiveness (Phase 2)Looking for participantsNCT07341737
What this trial is testing

SL-28 for Advanced Solid Tumours

Who this might be right for
Head & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more
Second Life Therapeutics 60
Testing effectiveness (Phase 2)Ended earlyNCT02062632
What this trial is testing

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Who this might be right for
Esophageal CarcinomaHypopharyngeal CarcinomaLaryngeal Carcinoma+11 more
Mayo Clinic 5
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Not applicableLooking for participantsNCT06431100
What this trial is testing

A Single-arm, Single-center, Open Clinical Study

Who this might be right for
Gastric CancerEsophageal CancerCervical Cancer+2 more
Beijing Geekgene Technology Co., LTD 10
Not applicableNot Yet RecruitingNCT06986291
What this trial is testing

Radiation-induced Toxicity of the Heart

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerBreast Cancer Female
Technische Universität Dresden 325
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Early research (Phase 1)Study completedNCT04045496
What this trial is testing

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Jacobio Pharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT07023731
What this trial is testing

Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

Who this might be right for
KRAS G12D MutationAdvanced Solid Cancer
Arvinas Inc. 76
Early research (Phase 1)Not Yet RecruitingNCT07814248
What this trial is testing

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more
TwoStep Therapeutics, Inc. 74
Testing effectiveness (Phase 2)UnknownNCT06231680
What this trial is testing

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Who this might be right for
Lung Cancer, Nonsmall CellEsophageal Carcinoma
Henan Cancer Hospital 132
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Not applicableStudy completedNCT00686465
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study

Who this might be right for
Non-small Cell Lung CancerBreast CancerHead and Neck Cancer+3 more
Ontario Clinical Oncology Group (OCOG) 101
Early research (Phase 1)Looking for participantsNCT05865002
What this trial is testing

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)

Who this might be right for
Relapsed Malignant Solid Neoplasm
Aurigene Discovery Technologies Limited 50
Testing effectiveness (Phase 2)Looking for participantsNCT05473156
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

Who this might be right for
Locally Advanced or Metastatic Solid TumorsNon Small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)+1 more
AP Biosciences Inc. 168
Early research (Phase 1)Study completedNCT04121286
What this trial is testing

JAB-3312 in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Allist Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Next Page